To experimentally evaluate, whether IL-34 and CSF-1 directly regulate breast cancer cells depending on their subtype, we assessed the effect of recombinant IL-34 and CSF-1 on luminal-like MCF7, HER-2-positive SK-BR-3, and basal type MDA-MB-231 breast cancer cells. Here, ERBB2 is linked to breast carcinoma.